Schedule 13D ownership disclosure
EQUILLIUM INC
Security class unavailable · CUSIP: 29446K106
Event date: 2021-02-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,271,423
- Percent of class
- 14.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-024389
- Form type
- SC 13D
- Filer
- Decheng Capital Global Life Sciences Fund IV, L.P.
- CIK
- CIK 1834150
- Filed
- Feb 16, 2021
- Reporting period
- Feb 05, 2021
- Description
- Schedule 13D beneficial ownership